An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria

drug protocol number

ELICA-M001

drug sponsor

Jamjoom Pharmaceuticals

drug study

Elica-M

drug trial site

King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase